US 11,655,252 B2
Aminopyrimidinyl derivatives
Brian Stephen Gerstenberger, Cambridge, MA (US); Wenhua Jiao, Salem, CT (US); Manjinder Singh Lall, East Lyme, CT (US); Ricardo Lira, East Lyme, CT (US); and Mark Edward Schnute, Acton, MA (US)
Assigned to Pfizer Inc., New York, NY (US)
Filed by Pfizer Inc., New York, NY (US)
Filed on Jun. 30, 2021, as Appl. No. 17/363,494.
Claims priority of provisional application 63/047,606, filed on Jul. 2, 2020.
Prior Publication US 2022/0002301 A1, Jan. 6, 2022
Int. Cl. C07D 471/18 (2006.01); A61K 45/06 (2006.01)
CPC C07D 471/18 (2013.01) [A61K 45/06 (2013.01); C07B 2200/13 (2013.01)] 20 Claims
1. A compound of formula I:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are each independently hydrogen or hydroxy; wherein R1 and R2 are not both hydroxy.